secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELLAS Life Sciences Group, Inc. (SLS)
CIK:        0001390478
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001104659-24-024898
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

SELLAS receives Nasdaq deficiency notice for bid price below $1.00; has 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified SELLAS on Feb 14, 2024 that common stock failed to maintain minimum $1.00 bid price for 30 consecutive business days.
- No immediate impact on listing or trading; stock continues trading under symbol SLS.
- Company has 180 calendar days, until Aug 12, 2024, to regain compliance by closing bid price >=$1.00 for 10 consecutive business days.
- If not compliant by Aug 12, may be eligible for additional 180-day period if it meets other listing standards and notifies Nasdaq of intent to cure via reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924024898/0001104659-24-024898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1390478/000110465924024898/tm246424d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-024898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer